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INTRODUCTION 
In the UK over 800,000 older people have dementia, 
which can lead to social exclusion, loss of identity and 
independence due to deterioration in cognition, activities 
of daily living, the double stigma of age and dementia, 
and the reduced capacity for social participation.
1
 The EU 
Joint Programme – Neurodegenerative Disease Research 
(JPND) has highlighted the need for psychosocial 
interventions promoting social inclusion, dignity, and the 
positive contributions to society that people with 
dementia can make.
2
 
People with early stage dementia are generally satisfied 
with their lives and feel their quality of life is „good‟ but 
can, following a dementia-diagnosis experience stigma, 
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feelings of hopelessness, insecurity, low self-esteem, and 
low confidence.
3,4
 Key concerns of people with dementia 
include loss of power in relationships with their family, 
the need to maintain a role outside the family, and a lack 
of basic information about diagnosis, prognosis, and 
care.
5
 Hobbies and interests are often lost early in the 
disease process, though there is evidence to suggest 
engaging in social, cognitive, and physical activities can 
slow down or prevent further cognitive deterioration and 
help preserve independence.
6-9
 Typically the person can 
become undermined by their diagnosis and the 
expectations and beliefs of others which may then lead to 
disengagement from life.
10
 Consequently, the person‟s 
„sense of agency and self‟ in many spheres of everyday 
life, can also be undermined.  
Supporters often misconstrue the values and preferences 
of people with dementia in relation to autonomy and 
consistently underestimate their decision-making 
ability.
11
 Responsibility for making decisions may be 
completely taken over by supporters, but many people 
with dementia see shared decision-making with family 
members as preferable.
12
 Those who lack opportunities to 
participate in decision making report feeling „unheard‟.13 
The assumption that the person lacks agency may also 
undermine their opportunities to initiate social action, and 
thus influence their own personal circumstances.
14
 These 
experiences may result in 'excess disability' whereby the 
person‟s reduced engagement with life is greater than 
would be expected for their impairment.
15
 The 
biopsychosocial model of dementia provides a theoretical 
framework to demonstrate how the person‟s social 
environment can reduce the risk and/or extent of excess 
disability experienced and optimise sense of self and 
independence.
16
  
Due to the false assumption that there is little to offer 
people with dementia, and the stereotype that they “forget 
the information given to them” people with dementia may 
not be encouraged to take an active role in managing their 
care.
17
 Post-diagnostic support is critical to enhancing 
and maintaining the functional capacity of people with 
dementia, and helping them continue to engage in life, 
with lack of effective or insufficient support being linked 
to failure to prioritise diagnosis rate.
18
 The utility of 
dementia advisory services was shown in a recent 
independent assessment of improvements in dementia 
care and support, which reported that the most improved 
clinical commissioning groups (CCG) were those which 
offered dementia advisory services.
18 
Aims 
The primary aim of the proposed study is to investigate 
the feasibility of the promoting independence in dementia 
(PRIDE) intervention delivered by DAWs designed to 
help facilitate the independence of people who have 
recently been diagnosed with dementia. 
The study aims to determine: 
 The acceptability of and engagement with the 
intervention 
 Barriers and facilitators of the intervention 
 The acceptability of outcome measures 
 Recruitment rate and retention 
 Fidelity of delivery of the intervention. 
METHODS 
The study is a mixed-methods feasibility trial of the 
PRIDE intervention. It will be non-randomised with all 
participants receiving the intervention. The study will 
integrate process evaluation, by assessing fidelity from 
the point of view of DAWs, persons with dementia and 
researchers. Engagement will be assessed from point of 
view of participants (person with dementia). The 
quantitative components of the trial will comprise of 
outcome assessments at baseline and immediately post 
intervention, intervention fidelity checklists, 
measurement of support required by the dyad (e.g., 
number of telephone support contacts, extra sessions 
required), and measurement of support required by the 
DAWs to deliver the intervention (e.g., number of 
support contacts and feedback about their training). 
Qualitative data on implementation, feasibility, and 
overall design of the intervention will be gathered from 
participants, supporters and DAWs in a series of semi-
structured interviews and focus groups, which will take 
place when the intervention is complete.  
Inclusion and exclusion criteria 
Up to 50 people with dementia and supporters (family, or 
friend) will be recruited across up to five sites in the UK. 
People with dementia 
People with dementia will meet the following eligibility 
criteria; community dwelling adults with a diagnosis of 
mild dementia.
19
 In order to be eligible, people with 
dementia will score 0.5-1 on the clinical dementia rating 
scale (CDR), indicating mild dementia and who have a 
supporter (see below) willing to participate in the study 
alongside them.
20
 Participants must be able to read and 
communicate verbally in English, and able to provide 
informed consent to participate in accordance with the 
Mental Capacity Act Department of Health.
21
  
Supporters 
The protocol and intervention are using the term 
supporter rather than carer. Participants will be managing 
well independently and the term denotes support as being 
part of an ordinary relationship with reciprocity. 
Supporters must be unpaid and in regular contact with the 
person for a minimum of three hours per week. They will 
need to be able to communicate in English. 
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Dementia advice workers 
Dementia advice workers (DAWs) delivering the 
intervention will be health, social care, or voluntary 
sector staff working in or alongside memory clinics. 
Managers of participating organisations will be asked to 
refer suitable members of staff who are able to read and 
communicate verbally in English, able to attend training 
sessions, and are available to deliver the intervention to 
one or more participants.  
Sample size 
We aim to recruit up to 50 dyads and from up to five 
sites. 
Procedure 
Research staff will collaborate with memory services and 
National Health Service (NHS), local authority, and 
voluntary organisations such as Dementia UK, the 
Alzheimer‟s Society, Age UK, and Join Dementia 
Research (JDR; a national register where individuals, 
regardless of age or diagnosis can apply to express an 
interest in taking part in dementia research, potential 
participants are then matched to appropriate studies) to 
recruit participants to the study. Eligible participants from 
the JDR register will be sent the information sheet and 
sheet and researcher contact details as well as being 
informed/asked via JDR pathways if they are interested in 
taking part.  
People with dementia and their supporters will be 
provided with study information when they express 
interest in the study. If they agree to participate, a 
member of the research team will visit them to seek 
written informed consent and then complete baseline 
measures with the person and their supporter. Participants 
will then be introduced to a local DAW who has been 
trained in the intervention protocol to deliver PRIDE 
programme. Participants and supporters will complete a 
follow up assessment up to three months after baseline 
assessment. Participants taking part in interviews or focus 
groups will sign a new consent form. Participants will be 
told that they can withdraw at any point without having to 
give a reason why, and without affecting the care they 
receive. A sample of persons with dementia, supports and 
DAWs will be invited to participate in interviews and 
focus groups after they have completed the intervention 
(Figure 1). 
Ethical approval 
Ethical approval was obtained through East Midlands 
Nottingham 1 Research Ethics Committee (ref no. 
16/EM/0044). Participants will be fully informed of the 
potential benefits and risks associated with the study. 
People with dementia will be in the mild stages of 
dementia, and will have the capacity to be able to provide 
informed consent, provided appropriate care is taken to 
explain the study. All information sheets, consent forms 
and recruitment material have been approved, and will be 
unique to participation in the intervention, interviews or 
focus groups. Safety procedures for researchers in the UK 
will follow standard guidelines and potential risks will be 
minimal. Reporting procedures for serious adverse events 
(SAEs) are in place and will be reported to the Chief 
Investigator.  
Development of the intervention 
The development and feasibility assessment of the 
PRIDE intervention follows the Medical Research 
Council (MRC) guidance for complex interventions 
incorporating the additional refined methodology (e.g., 
analysis of practical issues impacting fidelity) in order to 
minimise risk of implementation error.
22 
The evidence used to inform the development of the first 
draft of the manual and intervention was derived from the 
PRIDE team‟s expertise and work including; a literature 
review of the effectiveness of psychosocial interventions 
to promote and maintain independence in early-stage 
dementia, a scoping review of social participation in 
people with dementia living in the community, evidence 
from the English Longitudinal Study of Ageing (ELSA) 
cohort about the links between loneliness and cognitive 
decline, the role of physical activity/exercise 
interventions, and the use of computers and the internet in 
cognitive function.
23-27
 The research team developed a 
first draft of the intervention and manual with input from 
people with dementia, supporters, DAWs, older people, 
and healthcare professionals, consulting these groups in a 
series of informal meetings, and via email. The manual 
was then updated based on consultation feedback to 
create a second draft, which will be tested in this 
feasibility study. In the final stage of the development of 
the intervention the feasibility trial data will be used in 
conjunction with further stakeholder consultation to make 
any final amendments to the intervention before a large 
scale RCT is launched to evaluate its effectiveness. 
PRIDE intervention 
The intervention aims to promote independence and 
facilitate the person‟s access to opportunities to live well 
with dementia by: 
 Enabling the person to maintain a cognitively, 
physically, and socially active lifestyle 
 Helping the person to optimise the resources they 
have (e.g., cognitive skills, social networks) by 
finding a balance in activities based on the selection, 
optimisation with compensation (SOC) framework 
28
 
 Aiding the person to have a healthy lifestyle (e.g., 
weekly exercise) 
 Signposting to local services and resources 
 Helping the person maintain their social roles and 
agency in everyday decision-making 
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Figure 1: Participant flow through feasibility (one), fidelity (two) and qualitative (three) studies. 
The intervention includes a paper based manual with 
resources on communication, social connections, making 
decisions, keeping active (mentally, physically and 
socially), finding a balance in activities, adjusting to 
receiving a diagnosis of dementia, and keeping healthy. 
Each section features practical information drawn from 
clinical guidelines, factsheets issued by organisations 
such as the Alzheimer‟s Society, and the multi-
disciplinary clinical and research (e.g., evidence from 
trials) expertise of the PRIDE work group (e.g., old age 
psychiatry, occupational therapy, clinical psychology). 
Case stories have been developed based on data from 
interviews and work conducted in the PRIDE social and 
personal constructs of dementia qualitative study. For 
example, how people live well with dementia as well as 
challenges people commonly encounter, along with 
suggested strategies to tackle them. The person will 
choose resources in the manual that are most relevant to 
them. DAWs will provide supplementary materials and 
use their knowledge of local resources and services to 
signpost where necessary. 
The intervention consists of three sessions, each lasting 
about one to two hours each, delivered approximately 
every four weeks in the participant‟s home. In session 
one, the person will discuss important aspects of their 
current daily lives, how to maintain or enhance the 
activities/routines they value, and consider new activities 
they might benefit from. The person will map their social 
network to identify strengths and the areas where they 
may need extra support. Structured plans will be created 
and recorded to encourage the person to engage in 
particular activities or actions (e.g. spending 30 minutes 
walking twice a week). Between each session, the person 
and their supporter will try out strategies and activities 
they have planned together and record what they have 
Baseline 
Post Intervention Assessment 
Interviews/ 
Focus Groups 
Fidelity trial (n=) 
Memory services, NHS, local authority, voluntary 
organisations, JDR register 
Research sites: London, Hull, Nottingham, Leeds 
Feasibility trial (n=40-50) 
PRIDE intervention 
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done. In the second session, progress will be reviewed 
with the DAW. Plans may be refined according to the 
participant and supporters‟ experience in the first month. 
Barriers that prevented implementation of plans will also 
be identified, and solutions explored. In the third and 
final session, progress with be reviewed again, and a 
maintenance plan will be developed to encourage long-
term change.  
Participants will be able to receive telephone support 
from their DAW in between intervention sessions, which 
will be recorded by the DAW. DAWs will have access to 
support and supervision from the research team. 
DAW training 
All DAWs will be required to attend a day standardised 
training session to ensure the intervention is delivered as 
intended. The training package will be developed 
alongside the development of the intervention, based on 
literature, previous expert experience and consultations 
with people with dementia, supporters, healthcare 
professionals, older people and DAWs. 
The training will aim to give DAWs a comprehensive 
understanding of the intervention. It consists of; (1) an 
overview and aims of the PRIDE feasibility study, (2) 
discussion of the role of DAWs, (3) the intervention 
procedure, (4) content of the PRIDE manual, and (5) 
helping participants identify goals, make plans and 
review them and problem solve. DAWs will be provided 
with an accompanying training manual. The training will 
be delivered by the same research team members across 
the different sites in order to increase fidelity in delivery 
of the intervention. The training session comprises of 
presentations, demonstrations of techniques and role 
plays. DAWs will have the opportunity to actively 
practise the skills and try the exercises in the manual 
which will consolidate learning and enable the trainers to 
observe their initial understanding of the concepts 
presented. 
Screening and outcome measures 
Screening  
The clinical dementia rating scale (CDR) will be used to 
screen people with dementia.
20
 It rates impairment in six 
cognitive categories (memory, orientation, judgment and 
problem solving, community affairs, home and hobbies, 
and personal care) on a five-point scale (0-3). In order to 
be eligible, people with dementia will score 0-1, 
indicating mild dementia. The screening will be carried 
out by researchers. 
Outcome measures for the person with dementia 
The primary outcome will be functional ability of the 
person measured by the Bristol activities of daily living 
scale (BADLS).
29
 The measure is completed by the 
supporter and consists of 20 daily-living abilities. There 
is evidence to suggest the BADLS shows sensitivity to 
change in people with Alzheimer's disease receiving 
anticholinesterase medication and significantly correlates 
with changes in the Mini-Mental State Examination 
(MMSE), and the Alzheimer‟s disease assessment scale-
Cog (ADAS-Cog).
30,31
  
Secondary outcomes for the person will include; quality 
of life (QoL) (Dementia Quality of Life (DEMQOL), 
Control, autonomy, pleasure and self-realisation (CASP-
19); ICEpop CAPability measure for Older people 
(ICECAP-O), health-related QoL (EQ-5D, functional 
mobility (Timed up and go test), English Longitudinal 
Study of Aging (ELSA) self-perceived social 
connectedness questions,
 
verbal fluency and learning 
(Hopkins verbal fluency and learning test (HVLT), 
cognition (Standardised mini-mental state examination 
(S-MMSE), self-determination and participation (Impact 
on participation and autonomy (IPA), and subjective 
independence and social engagement (Engagement and 
Independence in dementia questionnaire (EID-Q)).
32-41
 
Resilience and hope will be measured using the positive 
psychology outcome measure (PPOM), self- management 
abilities will be measured by the Self-management 
abilities scale (SMAS-30).
41,42
 
Outcome measures for supporters 
The primary outcome for supporters will be supporter 
health-related QoL measured by the EQ-5D.
36
 The EQ-
5D is a measure of self-reported health outcomes that is 
applicable to a wide range of health conditions and 
treatments. It consists of two parts: a descriptive system 
(Part I) and a visual analogue scale (VAS) (Part II). Part I 
of the scale consists of five single-item dimensions 
including: mobility, self-care, usual activities, 
pain/discomfort, and anxiety/depression. Part II uses a 
vertical graduated VAS (thermometer) to measure health 
status, ranging from worst imaginable health state to best 
imaginable health state. 
QoL will be the secondary outcome for supporters and 
will be measured using the ICECAP-O.
34
 
Cost data 
Economic cost data on supporters‟ costs and participants‟ 
use of health and social care services will be gathered 
using the Client Services Receipt Inventory (CSRI).
43
 A 
retrospective period of three months will be examined. In 
particular, we will examine the completeness of the data. 
This will be led by the health economics team within the 
larger PRIDE study. 
The suitability of all measures, missing data and the 
length of time needed to complete the assessment will be 
assessed. Research staff carrying out the assessments will 
note if there are any particular difficulties with the 
measures. 
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Fidelity of delivery and engagement  
To assess fidelity of delivery, all intervention sessions 
will be audio-recorded and 60% of audio-recordings will 
be transcribed and rated against fidelity of delivery 
checklists, which were developed for the study. 
Checklists and coding guidelines will be piloted to ensure 
that inter-rater agreement is achieved before using them 
to assess fidelity of delivery.  
DAWs and participants will also be asked to complete the 
fidelity of delivery checklists to determine what they 
have delivered and what they have received. The 
participant fidelity checklists will also be used to assess 
engagement, including what participants have understood 
in each session and the skills they have used since the last 
session.  
Development of fidelity checklists 
To develop the checklists, previous fidelity measures 
were reviewed, intervention components were identified 
and a framework of components was developed before 
drafting the checklists. Feedback on the checklists was 
then sought from relevant public and patient involvement 
(PPI) members on the content and wording of the 
checklists and guidance. Two versions of the checklists 
and guidance for completing the checklists were 
developed for use by a) DAWs/researchers and b) 
participants. Different checklists were developed for each 
session of the intervention to capture all intervention 
components.  
Qualitative evaluation 
Interviews and focus groups will be carried out after 
participants and supporters have completed the 
intervention to determine if; (1) participants found the 
intervention and study procedures suitable and feasible, 
(2) whether they found the intervention useful and 
appropriate, and (3) barriers and facilitators to 
engagement. DAWs will also take part in interviews and 
focus groups to examine their experience of delivering 
the intervention, and barriers and facilitators to delivery. 
A consensus conference will be held in order to evaluate 
the final draft of the manual and intervention. Participants 
who took part in the intervention, experts in the field 
including academics and healthcare professionals, as well 
as people with dementia and carers will be invited to 
attend a half-day conference. Conference attendees will 
be sent copies of the manual prior to the conference to 
give them time to familiarise themselves with it. The 
conference will consist of presentations on the current 
status of the project, followed by workshop style 
discussions. Attendees will be split into multi-
disciplinary groups to promote varied discussion from 
several perspectives. Notes taken during the workshop 
discussions will be collated and suggested amendments 
will be incorporated into the final manual and 
intervention. 
Evaluation of recruitment capability and retention 
Referral sources (e.g. JDR, clinician referral), along with 
reasons for ineligibility, refusal and retention rates will be 
recorded. Reasons for dropout at each stage will be 
examined. Examining barriers to the recruitment of 
participants, DAWs and research sites will help inform 
planning the main RCT. Recruitment rates will be 
calculated. The acceptability and ease of use of the CDR 
tool and all outcome measures will be evaluated across 
all sites. 
We will record the organisations through which we find 
DAWs (e.g. Alzheimer‟s Society, voluntary sector or 
National Health Service [NHS] staff), and the type of 
DAWs (e.g., salary band, job description) who receive 
training. If DAWs attend the training but do not deliver 
the intervention we will record the reasons for this. The 
study will also evaluate the availability/capacity of DAW 
provider at each site. 
Analyses 
Descriptive analyses using means (with standard 
deviation) and percentages will be used to summarise the 
baseline characteristics of the participants. T-tests and 
correlations will be used to compare baseline and follow 
up data. The inter-rater agreement of researcher fidelity 
assessments will be assessed using the Kappa statistic. 
Fidelity of delivery and engagement will be assessed 
using descriptive statistics to compare across sites, 
providers, participants, and sessions. For example, 
fidelity of delivery will be calculated for each session in 
terms of the percentage of intervention components that 
were delivered as planned. A Pearson‟s correlation will 
be used to correlate the researcher, participant, and 
dementia advice worker ratings of fidelity. Missing data 
will be analysed in order to determine if there are any 
particular difficulties with any of the measures. 
DISCUSSION 
This protocol describes a mixed-methods feasibility trial 
of an intervention aiming to promote independence for 
people with mild dementia. The current study may offer a 
potential solution to the impoverished post-diagnostic 
experiences of many people with dementia and carers.
44
 
The direction of travel in memory services in England is 
to offer post diagnostic support from DAWs who can 
signpost people to ways in which they can live well with 
the condition. Our study will examine whether we can 
inform practice in line with current evidence on how 
people can engage with life to keep well. 
The current research about self-management programmes 
for people with dementia is limited.
4,45
 However, self-
management approaches based on social cognitive theory 
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can help people to understand the illness and build 
empowerment and coping strategies.
46
 For people with 
dementia developing and utilising self-management skills 
may enhance resilience, facilitate reciprocity, and help 
the person maintain their independence, sense of identity, 
activities, wellbeing, and relationships.
5
 The PRIDE 
intervention addresses the call for interventions which 
aim to ensure the voice of the person with dementia is 
heard; balancing the person‟s needs with those of the 
supporter, and involving the supporter and supportive 
others in the process of development and implementation 
of self-management skills.
47
 The intervention is person-
centred in that it provides options for the range of 
preferences of the person rather than using a „one size fits 
all‟ approach. A recent study showed that menu-based 
programmes which can be tailored to individual needs 
through offering choices are preferred by people with 
dementia.
5
 
In terms of contribution to the field, this study will add to 
knowledge of the feasibility of structured self-
management interventions. By incorporating process 
evaluation and gathering data on fidelity, the study may 
provide insight into the „active‟ components of this type 
of intervention that impact outcomes as well as 
identifying adaptations occurring in practice which may 
undermine intervention fidelity.
48 
We anticipate this 
information will be useful for the subsequent planned 
evaluation of the effectiveness of the PRIDE intervention 
in a large scale RCT, particularly in minimising risk of 
implementation errors and thereby increasing likelihood 
of detection of genuine effects of the intervention if they 
are present.
49
  
Self-management interventions may address the current 
"care gap" supporting people living with early stage 
dementia indicating the development of interventions like 
PRIDE is worthwhile. If the PRIDE intervention is found 
to be effective, the package could be adopted by NHS 
and voluntary dementia advisory services as part of 
routine practice. The long term impact of effective post-
diagnostic support via dementia advisory services and 
interventions such as PRIDE may be reductions in 
emergency inpatient admissions and premature care home 
admissions, and enhancement of service access rates in 
minority ethnic communities.
50
 The data gathered in this 
feasibility trial will be used to inform any necessary 
modifications to the PRIDE intervention and materials 
before the main RCT.  
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